SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001818
Filing Date
2022-05-23
Accepted
2022-05-23 09:25:55
Documents
75
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fwbi-20220331x10q.htm   iXBRL 10-Q 1491958
2 EX-31.1 fwbi-20220331xex31d1.htm EX-31.1 12050
3 EX-31.2 fwbi-20220331xex31d2.htm EX-31.2 12142
4 EX-32.1 fwbi-20220331xex32d1.htm EX-32.1 7639
  Complete submission text file 0001410578-22-001818.txt   7233060

Data Files

Seq Description Document Type Size
5 EX-101.SCH fwbi-20220331.xsd EX-101.SCH 80056
6 EX-101.CAL fwbi-20220331_cal.xml EX-101.CAL 47614
7 EX-101.DEF fwbi-20220331_def.xml EX-101.DEF 271813
8 EX-101.LAB fwbi-20220331_lab.xml EX-101.LAB 569393
9 EX-101.PRE fwbi-20220331_pre.xml EX-101.PRE 438582
69 EXTRACTED XBRL INSTANCE DOCUMENT fwbi-20220331x10q_htm.xml XML 1141880
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 22949742
SIC: 2834 Pharmaceutical Preparations